Article
Federal Circuit Considers The "Newly Characterized Antibody" Test In Amgen V. Sanofi But Might Pass On A Ruling
With four other issues before the court, including whether a new trial is required on written description and enablement, the court need not reach this issue to decide the case.
Finnegan, Henderson, Farabow, Garrett & Dunner LLP
